Arkolith/Insider Trading/BRTX/Form 4

Alstodt Lance

President, CEO, COB, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Jan 24, 2023
Net Buying
Open-Market Buys
$627
Open-Market Sells
$0
Net Open-Market Flow
$627
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2023Buy(P)100$3.10$310187K
Jan 20, 2023Buy(P)100$3.17$317187K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-001186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML